Adeline Gao Yuanhui

Research Analyst, Research & Portfolio Management

Adeline Gao Yuanhui is a Research Analyst with the iFAST Research & Portfolio Management Team, where she covers global macroeconomic themes and equity markets with a focus on Singapore. In addition to publishing research articles for iFAST, she has shared her insights through local media platforms such as Lianhe Zaobao. She graduated from the National University of Singapore (NUS) with a Bachelor of Business Administration (Honours) degree, double major in Finance and Economics.

Read More
Share
Category
Latest (Date)
ETF Spotlight: Greater China – One region, multiple growth driversETFs

ETF Spotlight: Greater China – One region, multiple growth drivers

Taiwan's AI hardware leadership and China's technology platform recovery are creating complementary growth opportunities across the Greater China region. The Global X FTSE Greater China ETF provides a convenient and cost-efficient way to gain diversified exposure to the region through a single investment vehicle.

By  Adeline Gao Yuanhui | 21 Jul 2026 |2884 Views
FSM SpotlightTencentTaiwanGreater ChinaHKEXChinaTSMCDiversificationHong KongValuationAIAlibaba2026 Outlook#2026
Singapore banks: Higher expectations, dividend appeal remains intactStocks

Singapore banks: Higher expectations, dividend appeal remains intact

Singapore banks have rallied to record highs on the back of strengthening earnings fundamentals, with robust non-interest income growth complemented by easing net interest margin pressure. As the sector heads into the 1H26 reporting season, the focus shifts from the recent re-rating to whether earnings can continue to justify higher valuations.

By  Adeline Gao Yuanhui | 16 Jul 2026 |725 Views
SGXWealth ManagementSingaporeFinancial ServicesFinancialOCBC2026EarningsInterest rateSG BanksDBSUOB1H26
UltraGreen.ai: Illuminating the future of surgeryStocks

UltraGreen.ai: Illuminating the future of surgery

We examine how UltraGreen.ai is positioned to capitalise on the structural adoption of fluorescence-guided surgery and assess its ability to deliver sustained earnings growth through its dominant ICG franchise, expanding global footprint and integrated surgical technology ecosystem.

By  Adeline Gao Yuanhui | 13 Jul 2026 |474 Views
SGXHealthcareHealthcareSmall to Medium CompaniesIPO2026Singapore EquitiesEQDPPharmaceutical
Rising SMID turnover and board lot reforms strengthens the case for SingaporeMacro Research

Rising SMID turnover and board lot reforms strengthens the case for Singapore

SMID turnover is now outpacing share price gains, alongside strong institutional inflows into high-quality companies, while upcoming board lot and custody reforms are set to improve accessibility for blue-chip stocks—signalling that Singapore's market revitalisation is broadening as it enters 2H26.

By  Adeline Gao Yuanhui | 07 Jul 2026 |545 Views
SGXSGX SMIDsMarket RevitalisationEquityGeneralSingaporeSingapore EquitiesEQDPMedium to Small Cap Companies2H26
Jumbo Group: East Coast closure prompts downgrade to TRIMStocks

Jumbo Group: East Coast closure prompts downgrade to TRIM

The upcoming closure of JUMBO's East Coast flagship—its founding site and contributor of approximately 14% of group revenue—creates a meaningful FY2027 earnings headwind. While new domestic initiatives and overseas expansion support a gradual recovery, the offset is backloaded, leaving limited upside at current level.

By  Adeline Gao Yuanhui | 30 Jun 2026 |353 Views
SGXConsumer CyclicalFood & BeverageSingapore EquitiesMedium to Small Cap Companies
The first KOSPI 200 ETF on HKEX has arrived. But is it the best way to invest Korea?ETFs

The first KOSPI 200 ETF on HKEX has arrived. But is it the best way to invest Korea?

Korea's AI-fuelled rally has arrived on HKEX through the debut of CSOP KOSPI 200 ETF (HKEX: 3121), but new access does not automatically mean better exposure. A comparison with existing Korea and Asia semiconductor ETFs shows that cost, concentration and investment objectives remain the key differentiators.

By  Adeline Gao Yuanhui | 23 Jun 2026 |1352 Views
NYSEHKEX
Will China's new capital rules derail Singapore's wealth hub story? We think notStocks

Will China's new capital rules derail Singapore's wealth hub story? We think not

China's new outbound investment rules have raised concerns over the future of wealth inflows into Singapore, but the implications for Singapore banks appear more manageable than initial market fears suggest. While the regulation adds friction to new Chinese capital flows, the structural drivers underpinning Singapore's wealth hub status and long-term wealth income growth remain firmly intact.

By  Adeline Gao Yuanhui | 19 Jun 2026 |1509 Views
SGXWealth ManagementSingapore BanksFinancial ServicesFinancialSingapore Equities#2026
Singapore's May NODX surges to 22-year high: AI integration runs deep, positive view maintainedMacro Research

Singapore's May NODX surges to 22-year high: AI integration runs deep, positive view maintained

Singapore's May NODX surged 38.4% year on year, marking its fastest growth in more than two decades. More importantly, the composition of exports highlights Singapore's deepening role in the global AI semiconductor supply chain, supporting the view that the current export upswing is driven by structural rather than cyclical factors.

By  Adeline Gao Yuanhui | 18 Jun 2026 |533 Views
SGXEquityGeneralMacroeconomicsSingaporeSemiconductorsExportElectronic NODXSingapore Equities#2026
Still expanding: What Singapore's ten-month PMI streak says about the road aheadMacro Research

Still expanding: What Singapore's ten-month PMI streak says about the road ahead

As global uncertainty deepens, Singapore's manufacturing sector is accelerating rather than retreating — and with safe-haven capital flows reinforcing the factory-floor data, the case for Singapore as the region's most resilient equity market is growing stronger.

By  Adeline Gao Yuanhui | 15 Jun 2026 |488 Views
SGXSingapore OutlookEquityGeneralExportManufacturingSingapore Equities#2026
Contained and contested: Why Singapore's US tariff risk is smaller than it appearsMacro Research

Contained and contested: Why Singapore's US tariff risk is smaller than it appears

Singapore’s inclusion in two concurrent US Section 301 investigations has heightened tariff concerns, but active policy engagement, and resilient structural growth drivers continue to support a constructive investment case for Singapore.

By  Adeline Gao Yuanhui | 09 Jun 2026 |427 Views
SGXEquityGeneralSingaporeExportManufacturingElectronic NODX2026US tariff